No abstract available
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bevacizumab
-
Camptothecin / administration & dosage
-
Camptothecin / analogs & derivatives
-
Cetuximab
-
Codon
-
ErbB Receptors / antagonists & inhibitors*
-
Fluorouracil / administration & dosage
-
GTP Phosphohydrolases / analysis
-
GTP Phosphohydrolases / genetics
-
Humans
-
Leucovorin / administration & dosage
-
Membrane Proteins / analysis
-
Membrane Proteins / genetics
-
Molecular Targeted Therapy / methods*
-
Mutation*
-
Organoplatinum Compounds / administration & dosage
-
Panitumumab
-
Polymerase Chain Reaction / methods
-
Proto-Oncogene Proteins / analysis
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins B-raf / analysis
-
Proto-Oncogene Proteins B-raf / genetics
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins / analysis*
-
ras Proteins / genetics*
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Codon
-
KRAS protein, human
-
Membrane Proteins
-
Organoplatinum Compounds
-
Proto-Oncogene Proteins
-
Bevacizumab
-
Panitumumab
-
EGFR protein, human
-
ErbB Receptors
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf
-
GTP Phosphohydrolases
-
NRAS protein, human
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins
-
Cetuximab
-
Leucovorin
-
Fluorouracil
-
Camptothecin
Supplementary concepts
-
Folfox protocol
-
IFL protocol